Opinion|Videos|September 12, 2024
Comprehensive Analysis: Upa Outshines Dupi Across Key Measures
Dermatology experts analyze the superior outcomes of upadacitinib compared with dupilumab across key efficacy measures in atopic dermatitis treatment.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on Dermatology Times
1
How Emerging Androgenetic Alopecia Therapies Target DHT at the Scalp Level
2
Tildrakizumab Partially Reverses Epigenetic Aging in Psoriasis, Pilot Study Shows
3
Field-Directed Therapy Favored for Actinic Keratosis Management
4
Diet Linked to Improved Chronic Idiopathic Urticaria Control
5